Micropos Medical

Enabling accuracy in prostate cancer care

Micropos Medical is a Swedish medical device company that develops, manufactures, and sells technology enabling enhanced radiotherapy cancer treatment. Its product Raypilot® System, generates high precision as well as high efficiency through real-time tumour tracking in radiation treatment of prostate cancer. Raypilot is marketed in Europe and the US.

The Micropos Medical share is traded under the stock ticker MPOS on the Spotlight Stock Market.

For more information about the share, please visit Spotlight

---

IR CALENDAR

---

• 30 January 2023 – Year-end report 2022
• 27 April 2023 – Interim report Q1 2023
• 27 July 2023 – Interim report Q2 2023
• 26 October 2023 – Interim report Q3 2023
• 31 January 2024 – Interim report Q4 2023

For additional information, please contact:
Thomas Lindström, CEO, Micropos Medical AB (publ)
+46-31-760 80 05, info@micropos.se

---